Golimumab Biosimilar - Research Grade

Human

TNFA

5mg/ml

Human IgG1 (E356D/M358L)-kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01375

Blue ice

Tumour necrosis factor alpha (TNF-alpha) is a master pro-inflammatory cytokine and a validated target across autoimmune and inflammatory disease research. This anti-human TNF-alpha recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of golimumab, provided strictly for research use only. Built to in vivo manufacturing standards with an ultra-pure, low-endotoxin formulation, it is produced in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. It serves as a consistent control and active reagent for preclinical work, scaling from in vitro neutralization screening to in vivo inflammatory disease models and biologics characterization.

CNTO 148,tumor necrosis factor (TNF) superfamily member 2, TNFSF2, TNF-alpha, TNFA

Detects human TNFA

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.